Argentina, Brazil and Canada outpacing U.S. in gene editing

U.S. pork producers will fall behind global competitors if the U.S. Food and Drug Administration continues to move forward with plans to regulate livestock gene editing as a drug. That was the message the National Pork Producers Council delivered during a media teleconference Tuesday on the current regulatory oversight of gene-edited livestock on America’s farms.

Gene editing accelerates genetic improvements that could be realized over long periods of time through breeding. It allows for simple changes in a pig’s native genetic structure without introducing genes from another species. Emerging applications include raising pigs resistant to porcine reproductive and respiratory syndrome, a highly contagious swine disease that causes significant animal suffering and costs pork producers worldwide billions of dollars.


By Ann Hess via National Hog Farmer


Read full article here

Share This

Chamber Updates Stay connected with Chamber activities